Biology Derived Solutions

From nature to clinics to cure neuroblastoma

Keywords

  • Biotech
  • Health
  • life sciences

Industries

Biotech

Abstract

[Idea Phase]

Neuroblastoma comprises 15% of cancer deaths in children. Up to 50% of high-risk cases do not respond adequately to therapy, and current therapies have a multitude of side effects.

BDS developed a panel of proteins with onco-suppressor role and a selection of peptides based on physiochemical properties (patent pending)

Info

Contatto: Giovanni Piccoli
Web: giovanni piccoli@ unitn it